BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11781411)

  • 1. Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000.
    Galasko D; Salmon DP; Craig UK; Thal LJ; Schellenberg G; Wiederholt W
    Neurology; 2002 Jan; 58(1):90-7. PubMed ID: 11781411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE.
    Galasko D; Salmon D; Gamst A; Olichney J; Thal LJ; Silbert L; Kaye J; Brooks P; Adonay R; Craig UK; Schellenberg G; Borenstein AR
    Neurology; 2007 May; 68(21):1772-81. PubMed ID: 17515539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lessons from Guam ALS/PDC study].
    Asao H
    Rinsho Shinkeigaku; 2007 Nov; 47(11):717-21. PubMed ID: 18210783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal and entorhinal cortex neurofibrillary tangle formation in Guamanian Chamorros free of overt neurologic dysfunction.
    Perl DP; Hof PR; Purohit DP; Loerzel AJ; Kakulas BA
    J Neuropathol Exp Neurol; 2003 Apr; 62(4):381-8. PubMed ID: 12722830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia.
    Sundar PD; Yu CE; Sieh W; Steinbart E; Garruto RM; Oyanagi K; Craig UK; Bird TD; Wijsman EM; Galasko DR; Schellenberg GD
    Hum Mol Genet; 2007 Feb; 16(3):295-306. PubMed ID: 17185385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seeking environmental causes of neurodegenerative disease and envisioning primary prevention.
    Spencer PS; Palmer VS; Kisby GE
    Neurotoxicology; 2016 Sep; 56():269-283. PubMed ID: 27050202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC).
    Miklossy J; Steele JC; Yu S; McCall S; Sandberg G; McGeer EG; McGeer PL
    Acta Neuropathol; 2008 Dec; 116(6):625-37. PubMed ID: 18843496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex.
    Mawal-Dewan M; Schmidt ML; Balin B; Perl DP; Lee VM; Trojanowski JQ
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1051-9. PubMed ID: 8858002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam.
    Poorkaj P; Tsuang D; Wijsman E; Steinbart E; Garruto RM; Craig UK; Chapman NH; Anderson L; Bird TD; Plato CC; Perl DP; Weiderholt W; Galasko D; Schellenberg GD
    Arch Neurol; 2001 Nov; 58(11):1871-8. PubMed ID: 11708997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years.
    Plato CC; Garruto RM; Galasko D; Craig UK; Plato M; Gamst A; Torres JM; Wiederholt W
    Am J Epidemiol; 2003 Jan; 157(2):149-57. PubMed ID: 12522022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroepidemiologic research initiatives on Guam: past and present.
    Wiederholt WC
    Neuroepidemiology; 1999; 18(6):279-91. PubMed ID: 10545780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam.
    Forman MS; Schmidt ML; Kasturi S; Perl DP; Lee VM; Trojanowski JQ
    Am J Pathol; 2002 May; 160(5):1725-31. PubMed ID: 12000724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
    Ince PG; Codd GA
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disappearance of ALS from Guam: implications for exogenous causes].
    Chen KM
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1549-53. PubMed ID: 8752460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALS and PDC of Guam: forty-year follow-up.
    Plato CC; Galasko D; Garruto RM; Plato M; Gamst A; Craig UK; Torres JM; Wiederholt W
    Neurology; 2002 Mar; 58(5):765-73. PubMed ID: 11889241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct pathological features of the gallyas- and tau-positive glia in the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
    Oyanagi K; Makifuchi T; Ohtoh T; Chen KM; Gajdusek DC; Chase TN
    J Neuropathol Exp Neurol; 1997 Mar; 56(3):308-16. PubMed ID: 9056545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological surveillance of amyotrophic lateral sclerosis and parkinsonism-dementia in the Commonwealth of the Northern Mariana Islands.
    Yanagihara RT; Garruto RM; Gajdusek DC
    Ann Neurol; 1983 Jan; 13(1):79-86. PubMed ID: 6830169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALS-parkinsonism-dementia complex of Kii and other related diseases in Japan.
    Kaji R; Izumi Y; Adachi Y; Kuzuhara S
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S190-1. PubMed ID: 22166431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of acquiring parkinsonism-dementia complex on Guam. 1944 through 1985.
    Zhang ZX; Anderson DW; Lavine L; Mantel N
    Arch Neurol; 1990 Sep; 47(9):1019-24. PubMed ID: 2396931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam.
    McGeer PL; Schwab C; McGeer EG; Haddock RL; Steele JC
    Neurology; 1997 Aug; 49(2):400-9. PubMed ID: 9270568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.